Intuitive Surgical's Guthart: "The first rule of being disruptive is having people who believe they can change the world"

March 28, 2012 by Brian Johnson

MassDevice discusses innovation, robotic surgery and Silicon Valley culture with Intuitive Surgical CEO Gary Guthart.

Gary Guthart knows a little something about disruptive innovation.

The 45-year-old CEO of Intuitive Surgical (NSDQ:ISRG) has been working to change the way minimally invasive surgery is performed since his days on the research team at SRI (formerly Stanford Research Institute). That group of Silicon Valley pioneers helped lay the foundation for the computer-enhanced surgery technology that helped launch the Sunnyvale, Calif.-based Intuitive. Named head of engineering in his early 30s, Guthart worked his way up the ranks at ISRG under predecessor Lonnie Smith, who took a seat on the board in early 2010 when Guthart took over the corner office.

Sign up to get our free newsletters delivered straight to your inbox

So far Guthart has delivered, increasing top-line performance 34% in his 1st year and opening up the da Vinci robot for several additional procedures. If the da Vinci truly changes the face of surgery, as the company claims it can, it will likely be under Guthart's watch.

Last year MassDevice named him one of the 5 most innovative CEOs in the industry. We caught up with him recently for a wide-ranging discussion on what makes him tick and what keeps Intuitive humming. We also discussed a recent study that questioned whether the cost of robotic surgery was worth price and what the future for computer-aided surgery looks like.

MassDevice: You started this journey as part of the core team at SRI. What was the central problem you addressed and did you solve it?

Features

The software flaw that allowed a duo of cybersecurity researchers to bring down a Philips XPER hospital management system with 6 lines of code is still a problem in current XPER machines, Philips tells MassDevice.com.

MassDevice.com discusses Boston Scientific's playbook for China, India, Russia and Brazil with Asia-Pacific president Supratim Bose.

Boston Scientific CFO Jeffrey Capello tells MassDevice.com how the medical device company plans to pull itself out of one of the roughest patches in its history.

Direct Flow Medical and CEO Bernie Lyons are betting that its heart valve technology can use the decade's worth of experience of the medical device industry's transcatheter aortic valve implant pioneers to leapfrog the competition.

Johns Hopkins patient safety expert Peter Pronovost on medical errors, medical device data and the role medtech must accept in preventing needless deaths.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp